Curis | CRIS - Equity Capital And Reserves


Curis reported $-13.99M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Amgen USD 8.66B 961M Dec/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Bayer EUR 25.95B 3.75B Dec/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
CSL USD 18.66B 2.75B Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Exelixis USD 2.16B 619K Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Incyte USD 5.17B 516.28M Dec/2025
Merck USD 51.85B 2.79B Sep/2025
Novartis USD 46.13B 1.38B Dec/2025
Pfizer USD 92.8B 4.11B Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025
Takeda JPY 7.64T 513.39B Dec/2025
TG Therapeutics USD 648.02M 40.8M Dec/2025
Verastem USD -15.53M 16.91M Sep/2025
Xoma USD 87.94M 15.5M Sep/2025